Use of oral anticoagulants in atrial fibrillation is highly variable and only weakly associated with estimated stroke risk: Cross-sectional population database study

Acute kidney injury in patients with decompensated heart failure

(2014) Natalie L Borman et al.   BRITISH JOURNAL OF HOSPITAL MEDICINE

Risk of stroke and oral anticoagulant use in atrial fibrillation: a cross-sectional survey

(2012) Tim A Holt et al.   BRITISH JOURNAL OF GENERAL PRACTICE

Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review

(2011) Dan Pugh et al.   AGE AND AGEING

2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

(2011) Valentin Fuster et al.   CIRCULATION

Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis

(2011) G. Y. H. Lip et al.   EUROPACE

Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation

(2011) Sue Jowett et al.   STROKE

Ischaemic stroke and bleeding rates in ‘real-world’ atrial fibrillation patients

(2011) Isla M. Ogilvie et al.   THROMBOSIS AND HAEMOSTASIS

The burden of psychotropic drug prescribing in people with dementia: a population database study

(2010) Bruce Guthrie et al.   AGE AND AGEING

A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation

(2010) Ron Pisters et al.   CHEST

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

(2010) et al.   EUROPACE

Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

(2010) G. Y. H. Lip et al.   EUROPEAN HEART JOURNAL

Stroke Prevention Versus Bleeding Risk in Atrial Fibrillation

(2010) Stefan H. Hohnloser   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A comparison of risk stratification schemes for stroke in 79 884 atrial fibrillation patients in general practice

(2010) T. P. VAN STAA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1

(2010) Laurent Gorin et al.   THROMBOSIS AND HAEMOSTASIS

Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at ‘moderate risk’ [CHADS2 score=1]: Simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice

(2010) Gregory Lip   THROMBOSIS AND HAEMOSTASIS

The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?

(2010) John W. Eikelboom et al.   THROMBOSIS AND HAEMOSTASIS

Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation

(2009) Carl van Walraven et al.   STROKE

Antithrombotic Therapy in Atrial Fibrillation

(2008) Daniel E. Singer et al.   CHEST

Initiation and persistence of warfarin or aspirin in patients with chronic atrial fibrillation in general practice: do the appropriate patients receive stroke prophylaxis?

(2008) A. M. GALLAGHER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS